Alpha Capital Partners

Alpha Capital Partners, established in 1984, is a Chicago-based private equity firm that provides equity financing to growth-stage businesses and established companies undergoing buyouts or recapitalizations. With a focus on the greater Midwest, they also consider nationwide investments. Currently, the firm manages over $135 million across three venture capital partnerships and other equity accounts, with an active fund of approximately $90 million. Alpha Capital Partners is a federally licensed Small Business Investment Company (SBIC) subsidiary.

Andrew Kalnow

Founder and President

John W. Rose

Principal

18 past transactions

Kuros Biosciences

Post in 2022
Kuros Biosciences AG is a biopharmaceutical company based in Schlieren, Switzerland, dedicated to the discovery, development, and commercialization of innovative products for tissue repair and regeneration. Founded in 2000 as a spin-off from the Eidgenössische Technische Hochschule Zürich, Kuros has developed a robust pipeline of biopharmaceuticals targeting chronic diseases. Its key products include Neuroseal, a novel biomaterial for dural sealing, and the MagnetOs family of bone graft substitutes used in orthopedic, spinal, and dental applications. MagnetOs is approved for use in the EU and the US, with further formulations under development for regulatory submission. Kuros also has a range of clinical-stage products, including KUR-111 and KUR-113, which have completed Phase II clinical trials for treating specific bone fractures. The company has engaged in significant clinical research, enrolling over 600 patients in multinational trials, generating promising data regarding safety and efficacy in various applications, particularly within orthobiologics.

Diagnostic Robotics

Series B in 2022
Diagnostic Robotics develops an artificial intelligence system for healthcare insurers, providers, and patients. Founded in 2017 and based in Tel Aviv, Israel, the company creates predictive analytics models to address clinical and financial challenges in healthcare. These models aim to optimize clinical program performance, increase return on investment, and enable more effective care at lower costs by allowing for informed decisions and proactive interventions.

Nanofabrica

Venture Round in 2020
Nanofabrica is a pioneering company based in Tel Aviv, Israel, specializing in 3D printing technology for precision manufacturing. Founded in 2016, the company focuses on micro and nanomanufacturing, offering solutions for various sectors, including semiconductors, optics, and medical devices. Its innovative Micro Adaptive Projection technology enables the production of ultra-precise and complex parts with an unprecedented micron-resolution. This capability allows for rapid manufacturing of high-performance components, significantly reducing costs and time compared to traditional methods. By integrating advanced optics and semiconductor lithography with 3D printing, Nanofabrica serves mass customization needs, responding to customer feedback to continuously refine its technology and expand into new markets such as robotics and biomedical applications.

Diagnostic Robotics

Series A in 2019
Diagnostic Robotics develops an artificial intelligence system for healthcare insurers, providers, and patients. Founded in 2017 and based in Tel Aviv, Israel, the company creates predictive analytics models to address clinical and financial challenges in healthcare. These models aim to optimize clinical program performance, increase return on investment, and enable more effective care at lower costs by allowing for informed decisions and proactive interventions.

Shree

Venture Round in 2019
Shree is based on the idea that you should never go out of vogue. Providing fast-fashion Indian wear along with unmatched value for the new age women, Shree has swiftly become one of the top seller brands on all the leading ecommerce stores like Snapdeal, Myntra, Jabong, Flipkart, Fashion and You, eBay, Homeshop18, Limeroad, India Emporium and more. We have 25 + exclusive Brand outlets in Delhi NCR, Telangana, Surat, Hissar and Uttarkhand. Our strong network of dealers and distributors, wholesalers and retailers, MBO’s in various states facilitate Shree to showcase products in 2000+ stores.

InCred

Series A in 2019
InCred Financial Services Limited is a non-banking financial corporation based in Mumbai, India, specializing in providing a range of loan products to retail, small and medium enterprises (SMEs), and commercial customers. Established in 1991, the company offers various types of loans, including personal, education, business, and two-wheeler loans, designed to meet diverse financial needs. InCred distinguishes itself by leveraging technology and data science to streamline the lending process, ensuring a quick and hassle-free experience for borrowers. The firm operates through two primary segments, Consumer Retail and SME, and aims to modernize lending practices in India while facilitating access to finance for its clientele.

Hero Electric

Venture Round in 2018
In the year 1956, the foundation of brand Hero was laid by Late Mr. Dayanand Munjal with a vision of providing mobility to millions in India. In the following years, the brand expanded itself enormously in varied fields like Bicycles, Motorcycles, Healthcare, etc. and became the most renowned & trusted name worldwide.

Credable

Series A in 2018
CredAble is a fintech platform that specializes in supply chain financing, aimed at enhancing working capital management for vendors, distributors, and dealers across Asia. By integrating technology, deep learning, and data analytics, CredAble provides tailored financial solutions that improve cash flow and strengthen supplier relationships. The platform enables businesses to access necessary funds against approved invoices, facilitating timely payments and operational efficiency. Through its innovative approach, CredAble supports companies in meeting their financial needs and seizing growth opportunities.

Another Brain

Venture Round in 2018
Another Brain, SA is a Paris-based company founded in 2017 that specializes in the development and manufacturing of bio-inspired chipsets designed for artificial intelligence and robotics applications. These innovative chipsets facilitate autonomous and unsupervised data extraction, enabling embedded pattern recognition and processing without reliance on external databases. They can detect and store multiple patterns simultaneously and learn from previously encountered patterns. The company also offers software tools to assist users in integrating the chipsets and conducting simulations. Another Brain's technology has diverse applications across various industries, including smart sensors, Internet of Things (IoT), smart cars, smart homes, robotics, drones, security, biometrics, defense, and data center optimization. By enhancing the capabilities of AI beyond traditional deep learning approaches, Another Brain aims to revolutionize how information is processed and utilized in numerous sectors.

BaishanCloud

Series C in 2018
BaishanCloud, founded in April 2015, is a provider of cloud-managed services that focuses on cloud resource exchanges and interactions. The company offers a comprehensive suite of services, including cloud delivery, cloud storage, and cloud linkages, designed to meet the diverse needs of enterprise customers. BaishanCloud emphasizes data governance and utilizes analytics-driven security policies and intelligent caching algorithms to ensure the security of data in transit. Its cloud management platform facilitates data migration, integration, acceleration, and analytics, effectively supporting clients in navigating multi-cloud infrastructures. With its innovative approach, BaishanCloud aims to enhance the efficiency and effectiveness of cloud services for businesses.

Just Buy Live

Series A in 2016
Just Buy Live is a prominent e-distributor operating in the New Commerce and Mobile Retail sectors, focusing on empowering retailers through its innovative platform. The company provides a comprehensive e-distribution service that connects retailers directly with brands, facilitating the procurement of a vast array of products across numerous categories. Its technology simplifies the buying process and enhances the overall retail experience, integrating financial services to support transactions. By enabling direct exchanges between retailers and consumers, Just Buy Live effectively streamlines the supply chain and fosters a more efficient marketplace.

Friendable

Post in 2015
Friendable, Inc. is a mobile-focused technology and marketing company based in Campbell, California, specializing in online dating and social networking. Founded in 2007, the company offers a platform that facilitates connections between users through its applications. The primary offering, Friendable, allows users to create one-on-one or group-style meetups, enhancing social interactions. Additionally, Friendable provides Fan Pass, a mobile application designed to connect fans with their favorite celebrities or artists. Originally known as iHookup Social, Inc., the company rebranded to Friendable, Inc. in September 2015, reflecting its commitment to fostering social connections through innovative mobile solutions.

LiveIntent

Series C in 2014
LiveIntent is a technology platform that enhances email as a marketing tool, allowing brands to effectively connect with their customers. The company specializes in people-based targeting, email monetization, and identity resolution, providing solutions that benefit both marketers and publishers. By facilitating direct engagement with audiences, LiveIntent helps businesses drive sales and increase revenue while ensuring user privacy is respected. The platform aims to bridge the gaps between brands and their target audiences, maximizing the potential of email marketing.

VeriTeQ

Venture Round in 2010
VeriTeQ is a technology company based in Delray Beach, Florida, specializing in identification solutions for animals and emergencies. Founded in 1993, the company offers a range of products including FDA-approved implantable microchips for pet identification, visual and radio frequency identification (RFID) ear tags for livestock tracking, and GPS search and rescue beacons designed for use on aircraft, ships, and by outdoor enthusiasts. Additionally, VeriTeQ develops RFID technologies for identifying implantable medical devices utilized in radiation therapy and is creating a data analytics platform aimed at enhancing evidence-based healthcare through the collection of treatment regimen data.

CEL-SCI

Venture Round in 2009
CEL-SCI Corporation is a biotechnology company headquartered in Vienna, Virginia, specializing in the research and development of immunotherapy products aimed at treating cancer and infectious diseases. The company's lead investigational product, Multikine, is undergoing a phase III clinical trial for the treatment of head and neck cancer. Additionally, CEL-SCI is advancing its Ligand Epitope Antigen Presentation System (LEAPS), a patented pre-clinical technology designed to stimulate the human immune system to combat various infections and medical conditions, including autoimmune diseases and allergies. The company is also working on multiple product candidates such as LEAPS-H1N1-DC for infectious diseases, and CEL-2000 and CEL-4000 for rheumatoid arthritis. Furthermore, CEL-SCI is developing LEAPS COV-19, an immunotherapy candidate targeting COVID-19, in collaboration with the University of Georgia’s Center for Vaccines and Immunology. Founded in 1983, CEL-SCI continues to leverage its expertise in drug discovery and development to address significant health challenges.

Aprecia Pharmaceuticals

Venture Round in 2007
Aprecia Pharmaceuticals, LLC is a pharmaceutical company specializing in the development and manufacturing of innovative drug delivery systems. Founded in 2003, the company is headquartered in Blue Ash, Ohio, and operates manufacturing facilities in East Windsor and New Jersey. Aprecia is known for its ZipDose technology, which enables orodispersible formulations of medications, making it easier for patients to take their prescribed drugs. The company’s product portfolio includes SPRITAM, an oral tablet formulation of levetiracetam designed to treat various seizure types. Additionally, Aprecia offers CustomRelease for diverse time-release profiles, NanoDose for submilligram dosing, and ImplantaDose for post-surgical management. Through its advanced technologies, Aprecia Pharmaceuticals aims to enhance patient compliance and improve therapeutic outcomes.

Cybra

Venture Round in 2006
CYBRA Corporation, founded in 1985 and headquartered in Yonkers, New York, specializes in barcode labeling and radio frequency identification (RFID) software and hardware products. Its flagship offering, MarkMagic, serves as a comprehensive middleware solution, enabling customers to design and print barcode labels, RFID tags, and electronic forms using various printers, including thermal and automated applicators. MarkMagic features a WYSIWYG label designer and supports over 350 printer types across major computing platforms such as Windows, Linux, and Unix. Additionally, the company provides Edgefinity IoT, an RFID platform that assists in tracking personnel, assets, and inventory, facilitating compliance with EPC mandates and enhancing security in large facilities. CYBRA's products are utilized across diverse industries, including retail, healthcare, manufacturing, and hospitality, making the company a key player in barcode and RFID technology solutions.

Somanta Pharmaceuticals

Venture Round in 2006
Somanta Pharmaceuticals is a development stage biopharmaceutical company focused on creating innovative therapies for cancer treatment. The company is exploring several promising drug candidates in pre-clinical stages, including Alchemix, which aims to disrupt the cancer cell growth cycle by selectively targeting DNA and inhibiting critical enzymes involved in DNA processing, thereby addressing drug-resistant tumors. Additionally, Somanta is developing Angiolix, a humanized monoclonal antibody designed to induce apoptosis in the blood vessels that supply tumors, and Prodrax, a molecule that selectively becomes toxic in low oxygen environments typical of tumors while remaining non-toxic to healthy tissues. The company also holds a license for Sodium Phenylbutyrate, exploring its potential applications in cancer and autoimmune diseases.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.